LUDOVISI, MANUELA
 Distribuzione geografica
Continente #
NA - Nord America 994
EU - Europa 457
AS - Asia 52
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Totale 1.509
Nazione #
US - Stati Uniti d'America 989
IE - Irlanda 324
DE - Germania 60
SG - Singapore 29
CN - Cina 14
CZ - Repubblica Ceca 14
IT - Italia 11
BE - Belgio 10
FI - Finlandia 8
GB - Regno Unito 7
TR - Turchia 6
CA - Canada 5
NL - Olanda 4
AT - Austria 3
AU - Australia 3
FR - Francia 3
BR - Brasile 2
CH - Svizzera 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
HU - Ungheria 1
IL - Israele 1
IN - India 1
IS - Islanda 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
PL - Polonia 1
RS - Serbia 1
SE - Svezia 1
ZA - Sudafrica 1
Totale 1.509
Città #
Chandler 411
Dublin 322
Bremen 40
Lawrence 40
Princeton 40
Ashburn 38
Wilmington 36
Cedar Knolls 28
New York 27
Los Angeles 21
Singapore 19
Brno 12
Brussels 10
Boardman 8
San Francisco 8
Dallas 6
Norwalk 6
Helsinki 5
Washington 4
Berlin 3
Culver City 3
Fremont 3
Istanbul 3
Lappeenranta 3
London 3
Munich 3
Tappahannock 3
Toronto 3
Vienna 3
Chicago 2
Clifton 2
Fara San Martino 2
Melbourne 2
Santa Clara 2
Zurich 2
Amsterdam 1
Atlanta 1
Barnsley 1
Beijing 1
Belgrade 1
Brdo 1
Canberra 1
Chisinau 1
Clearwater 1
Columbus 1
Council Bluffs 1
Denver 1
Dubai 1
Fairfield 1
Florence 1
Frankfurt am Main 1
Gauteng 1
Genoa 1
Guangzhou 1
Lincoln 1
Markham 1
Marseille 1
Modena 1
Olomouc 1
Oslo 1
Pune 1
Reykjavik 1
Riga 1
Rome 1
Rosendaal 1
Santo André 1
Shanghai 1
Sofia 1
Stockholm 1
Stoney Creek 1
Tel Aviv 1
Warsaw 1
Totale 1.160
Nome #
Case report: incomplete Cauda Equina Syndrome following a caesarean section with spinal anaesthesia 56
Sex ratio at birth: causes of variation and narrative review of literature 50
Preoperative local staging of endometrial cancer: Transvaginal sonography vs. magnetic resonance imaging 48
A prospective blinded comparison of the accuracy of transvaginal sonography and frozen section in the assessment of myometrial invasion in endometrial cancer 45
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: A pilot study 45
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: Updated results and long-term survival 43
Clinical and ultrasound characteristics of surgically removed adnexal lesions with largest diameter ≤ 2.5 cm: a pictorial essay 43
Imaging in gynecological disease (9): Clinical and ultrasound characteristics of tubal cancer 43
Ultrasound and color power Doppler in the detection of metastatic omentum: A prospective study 43
Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors 42
Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications 41
Imaging in gynecological disease (1): Ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor 41
Uterine perforation and small bowel incarceration 11 months after dilatation and curettage: sonographic and surgical findings 41
Endometrial cancer off-line staging using two-dimensional transvaginal ultrasound and three-dimensional volume contrast imaging: Intermethod agreement, interrater reliability and diagnostic accuracy 40
Ultrasound features of different histopathological subtypes of borderline ovarian tumors 40
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer 39
Clinical utility of trabectedin for the treatment of ovarian cancer: Current evidence 39
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 39
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: The CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group 38
Sonographic features of decidualized ovarian endometriosis suspicious for malignancy 38
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer 38
Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer 37
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients 37
Does quantitative analysis of three-dimensional power Doppler angiography have a role in the diagnosis of malignant pelvic solid tumors? A preliminary study 37
In reply 37
Frozen section examination of pelvic lymph nodes in endometrial and cervical cancer: Accuracy in patients submitted to neoadjuvant treatments 36
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: A phase II study 36
Agreement of two-dimensional and three-dimensional transvaginal ultrasound with magnetic resonance imaging in assessment of parametrial infiltration in cervical cancer 36
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 36
Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: A prospective study 36
Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy 35
Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: A case series with a review of the literature 35
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma 35
Ovarian cancer arising in endometrioid cysts: Ultrasound findings 34
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer 33
Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma [1] 32
Ultrasound appearance of breast cancer metastatic to uterine leiomyoma 32
The role of sonographic examination in the follow-up of gynecological neoplasms 31
Re: Factors affecting visualization of postmenopausal ovaries: Descriptive study from the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) 31
Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: A pilot study 26
Sonographic features of pelvic tuberculosis mimicking ovarian-tubal-peritoneal carcinoma 22
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 19
Pre-eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools. A Review of the Literature 14
Conservative Management and Ultrasound Follow-Up of Parasitic Myoma: Our Experience and Literature Review 12
Sonographic characteristics of ovarian Leydig cell tumor 12
Ultrasound Features and Clinical Outcome of Patients with Ovarian Masses Diagnosed during Pregnancy: Experience of Single Gynecological Ultrasound Center 10
Late third trimester diagnosis of congenital giant hemangioma complicated by the Kasabach-Merritt phenomen: a case report and literature review 10
Tertiary Cytoreduction for Isolated Lymphnode Recurrence (ILNR) Ovarian Cancer in a BRCA2 Mutated Patient: Our Experience and Prevalence of BRCA 1 or 2 Genes Mutational Status in ILNR 9
Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review 7
Using Radiomics and Machine Learning Applied to MRI to Predict Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer 7
Totale 1.666
Categoria #
all - tutte 10.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022320 0 0 0 0 0 42 6 11 14 49 16 182
2022/20231.068 87 99 78 94 77 72 43 59 414 13 24 8
2023/2024233 29 21 32 16 33 41 2 10 1 20 12 16
2024/202545 26 19 0 0 0 0 0 0 0 0 0 0
Totale 1.666